+

WO2000008208A3 - Transcription inverse, amplification, et leurs amorces - Google Patents

Transcription inverse, amplification, et leurs amorces Download PDF

Info

Publication number
WO2000008208A3
WO2000008208A3 PCT/GB1999/002579 GB9902579W WO0008208A3 WO 2000008208 A3 WO2000008208 A3 WO 2000008208A3 GB 9902579 W GB9902579 W GB 9902579W WO 0008208 A3 WO0008208 A3 WO 0008208A3
Authority
WO
WIPO (PCT)
Prior art keywords
heeled
reverse transcription
primers
amplification processes
primers therefor
Prior art date
Application number
PCT/GB1999/002579
Other languages
English (en)
Other versions
WO2000008208A2 (fr
Inventor
Thomas Charles Freeman
Peter John Richardson
Alistair K Dixon
Original Assignee
Medical Res Council
Thomas Charles Freeman
Peter John Richardson
Alistair K Dixon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council, Thomas Charles Freeman, Peter John Richardson, Alistair K Dixon filed Critical Medical Res Council
Priority to AU52943/99A priority Critical patent/AU5294399A/en
Publication of WO2000008208A2 publication Critical patent/WO2000008208A2/fr
Publication of WO2000008208A3 publication Critical patent/WO2000008208A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé permettant -'établir le profil d'expression de cellules isolées. Le procédé utilise une première amorce à « talon » (heeled) pour la transcription inverse d'ARNm dans un échantillon afin de produire des espèces d'ADNc à premier brin, et puis une deuxième population d'amorces à « talon » pour générer des ADNc à second brin. La partie « non-talon » (non-heeled) des secondes amorces « à talon » peuvent s'hybrider aux premiers brins transcrits inverses d'espèces d'ADNc, à raison d'au moins un brin sur toutes les longueurs correspondantes. La présence de séquences aléatoires et de séquences présélectionnées dans les secondes amorces permet de créer, à partir d'ARNm cellulaires, un profil d'ADNc qualitativement plus uniforme et donc plus représentatif. --
PCT/GB1999/002579 1998-08-05 1999-08-05 Transcription inverse, amplification, et leurs amorces WO2000008208A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU52943/99A AU5294399A (en) 1998-08-05 1999-08-05 Reverse transcription and amplification processes and primers therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9817055.8A GB9817055D0 (en) 1998-08-05 1998-08-05 Reverse transcription and amplification processes and primers therefore
GB9817055.8 1998-08-05

Publications (2)

Publication Number Publication Date
WO2000008208A2 WO2000008208A2 (fr) 2000-02-17
WO2000008208A3 true WO2000008208A3 (fr) 2000-05-11

Family

ID=10836764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/002579 WO2000008208A2 (fr) 1998-08-05 1999-08-05 Transcription inverse, amplification, et leurs amorces

Country Status (3)

Country Link
AU (1) AU5294399A (fr)
GB (1) GB9817055D0 (fr)
WO (1) WO2000008208A2 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946251B2 (en) 2001-03-09 2005-09-20 Nugen Technologies, Inc. Methods and compositions for amplification of RNA sequences using RNA-DNA composite primers
US7094536B2 (en) 2001-03-09 2006-08-22 Nugen Technologies, Inc. Methods and compositions for amplification of RNA sequences
US7294461B2 (en) 2000-06-26 2007-11-13 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
US7402386B2 (en) 2003-04-14 2008-07-22 Nugen Technologies, Inc. Global amplification using random priming by a composite primer
US7771934B2 (en) 2000-12-13 2010-08-10 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
US7846666B2 (en) 2008-03-21 2010-12-07 Nugen Technologies, Inc. Methods of RNA amplification in the presence of DNA
US7939258B2 (en) 2005-09-07 2011-05-10 Nugen Technologies, Inc. Nucleic acid amplification procedure using RNA and DNA composite primers
US8034568B2 (en) 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
US8143001B2 (en) 2003-12-29 2012-03-27 Nugen Technologies, Inc. Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378070A1 (fr) * 1999-07-19 2001-01-25 Cambridge University Technical Services Limited Procede d'amplification de sequences d'acide nucleique peu abondantes et moyens mis en oeuvre pour ce procede
US6692918B2 (en) * 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
WO2002048352A1 (fr) * 2000-12-12 2002-06-20 Aisin Seiki Kabushiki Kaisha Methode d'analyse d'expression genique
EP1275738A1 (fr) * 2001-07-11 2003-01-15 Roche Diagnostics GmbH Procédé pour la synthèse aléatoire et l'amplification d'ADNc
DE60234369D1 (de) 2001-09-19 2009-12-24 Alexion Pharma Inc Manipulierte matrizen und ihre verwendung bei der single-primer-amplifikation
US7414111B2 (en) 2001-09-19 2008-08-19 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
US7176025B2 (en) 2002-03-11 2007-02-13 Nugen Technologies, Inc. Methods for generating double stranded DNA comprising a 3′ single stranded portion and uses of these complexes for recombination
GB0216026D0 (en) * 2002-07-10 2002-08-21 Cambridge Biotechnology Ltd Nucleic acid amplification method
CN105861487B (zh) 2012-01-26 2020-05-05 纽亘技术公司 用于靶向核酸序列富集和高效文库产生的组合物和方法
SG11201408478QA (en) 2012-06-18 2015-02-27 Nugen Technologies Inc Compositions and methods for negative selection of non-desired nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
EP2971130A4 (fr) 2013-03-15 2016-10-05 Nugen Technologies Inc Séquençage séquentiel
CA2929596C (fr) 2013-11-13 2022-07-05 Nugen Technologies, Inc. Compositions et procedes pour l'identification d'une lecture de sequencage en double
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
US10102337B2 (en) 2014-08-06 2018-10-16 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015601A1 (fr) * 1990-04-05 1991-10-17 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Reaction en chaine de polymerase specifique de reproduction d'a.r.n. modifiee
WO1998008973A1 (fr) * 1996-08-29 1998-03-05 Cancer Research Campaign Technology Limited Amplification globale d'acides nucleiques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015601A1 (fr) * 1990-04-05 1991-10-17 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Reaction en chaine de polymerase specifique de reproduction d'a.r.n. modifiee
WO1998008973A1 (fr) * 1996-08-29 1998-03-05 Cancer Research Campaign Technology Limited Amplification globale d'acides nucleiques

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEUNG AND NELSON: "WHOLE GENOME AMPLIFICATION USING A DEGENERATE OLIGONUCLEOTIDE PRIMER ALLOWS HUNDREDS OF GENOTYPES TO BE PERFORMED ON LESS THAN ONE NANOGRAM OF GENOMIC DNA", PNAS, vol. 93, 1996, pages 14676 - 14679, XP002128316 *
DIXON ET AL.: "EXPRESSION PROFILING OF SINGLE CELLS USING 3 PRIME END AMPLIFICATION (TPEA) PCR", NUCLEIC ACIDS RESEARCH, vol. 26, no. 19, October 1998 (1998-10-01), pages 4426 - 4431, XP002128317 *
FROUSSARD: "A RANDOM-PCR METHOD (rPCR) TO CONSTRUCT WHOLE cDNA LIBRARY FROM LOW AMOUNTS OF RNA", NUCLEIC ACIDS RESEARCH, vol. 20, no. 11, 1992, pages 2900, XP002128315 *
TELENIUS H ET AL: "DEGENERATE OLIGONUCLEOTIDE-PRIMED PCR: GENERAL AMPLIFICATION OF TARGET DNA BY A SINGLE DEGENERATE PRIMER", GENOMICS,US,ACADEMIC PRESS, SAN DIEGO, vol. 13, 1992, pages 718-725, XP000199116, ISSN: 0888-7543 *
ZHAO ET AL.: "3'-END cDNA POOL SUITABLE FOR DIFFERENTIAL DISPLAY FROM A SMALL NUMBER OF CELLS", BIOTECHNIQUES, vol. 24, May 1998 (1998-05-01), pages 842 - 852, XP002128314 *
ZHAO ET AL.: "NEW PRIMER STRATEGY IMPROVES PRECISION OF DIFFERENTIAL DISPLAY", BIOTECHNIQUES, vol. 18, no. 5, 1995, pages 842 - 850, XP002128267 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
US7294461B2 (en) 2000-06-26 2007-11-13 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
US7771934B2 (en) 2000-12-13 2010-08-10 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
US8334116B2 (en) 2000-12-13 2012-12-18 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
US7351557B2 (en) 2001-03-09 2008-04-01 Nugen Technologies, Inc. Amplification of RNA sequences using composite RNA-DNA primers and strand displacement
US7771946B2 (en) 2001-03-09 2010-08-10 Nugen Technologies, Inc. Methods, kits and compositions for single primer linear isothermal amplification of nucleic acid sequences
US7094536B2 (en) 2001-03-09 2006-08-22 Nugen Technologies, Inc. Methods and compositions for amplification of RNA sequences
US9181582B2 (en) 2001-03-09 2015-11-10 Nugen Technologies, Inc. Compositions for amplification of RNA sequences using composite primers
US8071311B2 (en) 2001-03-09 2011-12-06 Nugen Technologies, Inc. Methods and compositions for amplification of RNA sequences
US6946251B2 (en) 2001-03-09 2005-09-20 Nugen Technologies, Inc. Methods and compositions for amplification of RNA sequences using RNA-DNA composite primers
US7402386B2 (en) 2003-04-14 2008-07-22 Nugen Technologies, Inc. Global amplification using random priming by a composite primer
US9175325B2 (en) 2003-04-14 2015-11-03 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
US8465950B2 (en) 2003-04-14 2013-06-18 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
US8143001B2 (en) 2003-12-29 2012-03-27 Nugen Technologies, Inc. Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
US8852867B2 (en) 2005-09-07 2014-10-07 Nugen Technologies, Inc. Nucleic acid amplification procedure using RNA and DNA composite primers
US7939258B2 (en) 2005-09-07 2011-05-10 Nugen Technologies, Inc. Nucleic acid amplification procedure using RNA and DNA composite primers
US8034568B2 (en) 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
US7846666B2 (en) 2008-03-21 2010-12-07 Nugen Technologies, Inc. Methods of RNA amplification in the presence of DNA
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing

Also Published As

Publication number Publication date
AU5294399A (en) 2000-02-28
WO2000008208A2 (fr) 2000-02-17
GB9817055D0 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
WO2000008208A3 (fr) Transcription inverse, amplification, et leurs amorces
ATE328075T1 (de) Verfahren zur hemmung der expression eine zielgens
WO2003012052A3 (fr) Inhibition specifique d'expression de gene par de petits arns double brin
ATE297463T1 (de) Verfahren und medikament zur hemmung der expression eines vorgegebenen gens
EP1552018A4 (fr) Procedes et compositions associes au silen age genique
WO2001025488A3 (fr) Procede d'enrichissement en arn messager antisens naturel
CA2322073A1 (fr) Procede d'amplification non specifique d'acide nucleique
GB2284209A8 (en) Nucleic acid analogue-induced transcription of RNAfrom a double-stranded DNA template
CA2267524A1 (fr) Identification de la liaison d'un oligonucleotide non codant
DE602004001956D1 (de) Sehr dünner, hochkohlenstoffhaltiger Stahldraht und Verfahren zu dessen Herstellung
WO1993001286A3 (fr) Therapie localisee utilisant des oligonucleotides
WO2003040294A3 (fr) Procede de synthese in vitro de brins d'arn bicatenaires courts
DE60038952D1 (de) Verstärkungsschicht für reifen,verfahren zur herstellung derselben, und verfahren zur herstellung des reifens
ATE400650T1 (de) Verfahren zur herstellung von nukleinsäuremolekülen
ATE228039T1 (de) Strangpresswerkzeug sowie verfahren zu dessen herstellung
WO2002083943A3 (fr) Procede a microreseau permettant d'enrichir des fragments d'adn provenant de melanges complexes
ATE276863T1 (de) Verfahren zur herstellung von porösen polymerpellets
WO2001036669A3 (fr) Procede pour la realisation controlable d'amplifications par pcr complexes
WO2001006004A3 (fr) Procede d'amplification de sequences d'acide nucleique peu abondantes et moyens mis en oeuvre pour ce procede
WO1997049832A3 (fr) Procede d'identification du cytochrome p450
WO2004015159A3 (fr) Element coupant inoxydable et resistant a l'usure de rasoir electrique, rasoir electrique et procede de production de cet element coupant
WO2001068910A3 (fr) Oligonucleotides ou oligomeres de pna, et procede de detection parallele de l'etat de methylation d'un adn genomique
AU2003296089A1 (en) High strength thin steel sheet excellent in hole expansibility, ductility and chemical treatment characteristics, and method for production thereof
WO1997046673A3 (fr) Inhibition de la replication du vih-1 au moyen de l'expression d'arn antisens
EP0285593B1 (fr) Procédé pour améliorer la résistance à la corrosion d'une barre d'armature en acier trempé et auto-revenu

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载